PRVA
Privia Health Group, Inc.
$27.21
-0.02 (-0.07%)
At close · Jul 8
Market Cap
$3.43B
Shares
126,012,374
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$27.21
Open$27.14
Day$26.71–27.45
52W$18.77–27.70
Avg vol 30d1.1M
Short int3.0M · 2.4% float · 2.9d
Short vol31%
Last earningsAug 6, 2026
DataApr 2021–Jul 2026
Filing10-Q · May 7
Equibles Rating
blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical
Strong Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Moderate
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
Golden cross
Price vs 200-day avg
+16%
above
Price vs 50-day avg
+15%
above
RSI (14)
79
overbought
MACD trend
Positive
52-week position
95%
near high
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+27%
trailing
6-month return
+18%
trailing
YTD return
+15%
this year
Relative strength
+10%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
Golden cross
50d $24 › 200d $23 — 50d above 200d
Institutional flow
Distributing
8 of 292 funds reported for Jun 30 · net -1.8K sh shares · +1 new
Insider flow
Distributing
Net -$3.5M over 90 days · 100% sells
Short interest
Falling
2.38% of float · ▼ -10.0% MoM · 2.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
292 holders — near 3-yr high, broad support
Squeeze score
39
low risk · 0–100
Fundamentals
EPS growth
+64%
Y/Y
Free cash flow
$163.3M
Valuation
P/E 160.1
rich
Balance sheet
$479.7M
net cash
Quant / Vol
risk profile
Volatility
33%
annualized · 1-yr
Max drawdown
−24%
past year
ATR
2.6%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
Next earnings call
Aug 6, 2026
Scheduled
· in 4 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 7, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Guidance & track record
Latest guidance
· from the 8-K filed May 7, 2026
FY 2026
Practice Collections
Initiated
$3.65B – $3.75B
GAAP Revenue
Initiated
$2.35B – $2.45B
Care Margin
Initiated
$515M – $530M
Platform Contribution
Initiated
$260M – $270M
Adjusted EBITDA
Maintained
$145M – $155M
full-year 2026
Adjusted EBITDA to free cash flow conversion
Initiated
up to 80%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong Buy
50 / 200-day cross
Golden cross
Bullish
Price vs 200-day avg
+16%
Bullish
Price vs 50-day avg
+15%
Bullish
RSI (14)
79
Bearish
MACD trend
Positive
Bullish
52-week position
95%
Bullish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
Golden cross
50d $24 › 200d $23 — 50d above 200d
Institutional flow
Distributing
8 of 292 funds reported for Jun 30 · net -1.8K sh shares · +1 new
Insider flow
Distributing
Net -$3.5M over 90 days · 100% sells
Short interest
Falling
2.38% of float · ▼ -10.0% MoM · 2.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
292 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $19
Now $27 · 95%
52-wk high $28
vs 200-day avg +16%
vs 50-day avg +15%
50-day above 200-day golden cross
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $36.7M | Three Months Ended March 31 | -70.8% |
|
|
|||
| Care Margin non-GAAP | $128.7M | Three Months Ended March 31 | -72.2% |
|
|
|||
| Implemented Providers | 5,535 | Three Months Ended March 31 | +2.9% |
|
|
|||
| Practice Collections | $914.8M | Three Months Ended March 31, 2026 | -73.6% |
|
|
|||
| Value-Based Care Attributed Lives | 1,606,000 | Three Months Ended March 31 | — |
| commercial attributed lives | 913,000 | Q1 FY2026 call | — |
| EBITDA margin as a percentage of care margin non-GAAP | 28.5% | Q1 FY2026 call | — |
| implemented providers (sequential) | 155 | Q1 FY2026 call | — |
| patients | 5.9M | Q1 FY2026 call | — |
| value-based attributed lives | 1.6M | Q1 FY2026 call | — |
| Attributed Lives | 1,541,000 | FY2025 | — |
| Platform Contribution non-GAAP | $234.8M | FY2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Health Information Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
PRVA
this stock
Privia Health Group, Inc.
|
$3.43B | +14.8% | — | 160.1 | 2.4% |
|
VEEV
Veeva Systems Inc
|
$30.70B | -13.9% | +28.1% | 33.5 | 4.6% |
|
PMDIY
Pro Medicus Ltd./ADR
|
$15.67B | -9.4% | — | — | 0.0% |
|
BTSG
BrightSpring Health Services, Inc.
|
$13.67B | +88.3% | -0.4% | 50.4 | 4.8% |
|
TEM
Tempus AI, Inc.
|
$10.79B | +1.8% | +65.8% | — | 21.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| PRVA | +5.8% | +27.1% | +18.1% | +5.8% | +14.8% |
| SPY | +0.9% | +1.4% | +7.6% | +0.1% | +9.7% |
| vs SPY | +4.8% | +25.7% | +10.5% | +5.6% | +5.1% |